Why the study?
Does naringin prevent doxorubicin-induced cardiomyopathy in rats?
Does naringin prevent doxorubicin-induced cardiomyopathy in rats?
Naringin may offer cardioprotection against doxorubicin-induced acute cardiac toxicity in a rat model.
Answers are grounded in this paper and cite their sources.
Does not support clinical use with doxorubicin; hypothesis-generating for naringin cardioprotection in humans.
NR can be used in combination with Dox due to its high cardioprotective effect against Dox-induced cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Kwatra et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: